Genta (company)

Genta Incorporated was an American biopharmaceutical company that focused on the development and commercialization of drugs for the treatment of patients with cancer. The company was founded in 1988 and was based in Berkeley Heights, New Jersey. Genta Incorporated was known for its development of Gallium Nitrate, a drug used for the treatment of cancer-related hypercalcemia, and Genasense, a drug used for the treatment of melanoma.

History

Genta Incorporated was founded in 1988 by Dr. Raymond P. Warrell, Jr., a renowned oncologist. The company was initially focused on the development of new drugs for the treatment of cancer. In 1991, Genta Incorporated received approval from the Food and Drug Administration (FDA) for its drug Gallium Nitrate, which was used for the treatment of cancer-related hypercalcemia.

In 2004, Genta Incorporated developed Genasense, a drug used for the treatment of melanoma. However, the FDA did not approve the drug due to concerns about its effectiveness and safety. Despite this setback, Genta Incorporated continued to develop other drugs and therapies for the treatment of cancer.

In 2012, Genta Incorporated filed for bankruptcy and ceased operations. The company's assets were sold to various other pharmaceutical companies.

Products

Genta Incorporated developed several drugs for the treatment of cancer, including:

• Gallium Nitrate: A drug used for the treatment of cancer-related hypercalcemia. It was approved by the FDA in 1991.
• Genasense: A drug used for the treatment of melanoma. It was not approved by the FDA due to concerns about its effectiveness and safety.

See also

• Biopharmaceutical
• Cancer
• Food and Drug Administration